Felix Biotech lands grant for machine learning

By The Science Advisory Board staff writers

September 3, 2021 -- Felix Biotechnology was recently awarded a $256,000 Small Business Innovation Research phase I grant by the National Science Foundation to further enhance the company's machine-learning technology.

The grant will be used to fund Felix's machine-learning approach for engineering bacteriophage as a novel treatment for drug-resistant bacterial infections.

The funds will support Felix's efforts in engineering phage for improved efficacy and utility, starting with proof-of-concept work in Pseudomonas aeruginosa, a pathogen of high clinical need, the company said.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.